Lipitor
Caution raised on statins in healthy people
January 20, 2011Sales and Marketing Cochrane, Crestor, Lipitor, statin, statin prescribing
Researchers have warned of a lack of evidence to support prescribing statins in patients at low risk of developing heart …
Pfizer expands Lipitor recall
December 24, 2010Manufacturing and Production Lipitor, Pfizer, manufacturing compliance, recalls
Pfizer has been forced to recall another 19,000 bottles of its cholesterol-lowering drug Lipitor in the US after consumers reported …
Surprise exit for Pfizer chief executive Jeffrey Kindler
December 6, 2010Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Jeffrey Kindler, Lipitor, Pfizer, Wyeth, executive succession
Pfizer’s chief executive Jeffrey Kindler has unexpectedly stepped down, saying his time at the helm of the world’s largest pharmaceutical …
Pfizer pulls more Lipitor over odour problem
November 2, 2010Manufacturing and Production Lipitor, Lipitor recall, Pfizer, manufacturing compliance, recalls
Pfizer has widened its Lipitor recall after yet another incident in which consumers reported a musty smell emanating from bottles …
Pfizer recalls Lipitor tablets because of ‘musty’ smell
October 22, 2010Manufacturing and Production Lipitor, Pfizer, pharma recalls, product recalls
Pfizer has recalled 191,000 bottles of its cholesterol drug Lipitor in the US after customers complained of an unusual, musty …
Pfizer still at number 1, but Lipitor to slip
May 4, 2010Sales and Marketing Humira, Lipitor, Pfizer, sales
New research suggests that the pharma world is going to be shaken up over the next few years – although …
Wyeth acquisition yet to shake Pfizer’s Lipitor dependence
February 4, 2010Sales and Marketing 2009 financials, Lipitor, Pfizer
Pfizer’s profits rose by 7% last year on the back of a 4% increase in revenue driven by cholesterol treatment …
Danish court overturns Lipitor patent challenge
September 5, 2008Sales and Marketing Denmark, Lipitor, Pfizer, generics
A court in Denmark has ruled in favour of Pfizer in challenges to patents on the active ingredient – atorvastatin …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
